News Quantified

ABBV – abbvie inc. (US:NASDAQ)

AbbVie (ABBV) was given a new $262.00 price target by Canaccord Genuity Group Inc..

4/20

03:08 pm

abbv

Low

AbbVie and BioLabs Team Up to Support Life Sciences Innovation in Canada [Yahoo! Finance]

Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases [Yahoo! Finance]

AbbVie (ABBV) Is One Of The Major Stock To Buy According To Wall Street [Yahoo! Finance]

The Best High-Yield Dividend Stocks to Buy for 2026 and Beyond [Yahoo! Finance]

Live Event: Join our next subscriber-only event: "The Data Driven Investor"

Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}